Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Abrezekimab (Anti-IL-13) For research use only.
Not for use in humans.

Abrezekimab (Anti-IL-13)

Synonyms: UCB4144; VR 942

Abrezekimab (anti-IL-13) is a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. It can be used in research of asthma. MW: 145.5 KD.

Abrezekimab (Anti-IL-13)

Purity & Quality Control

≥99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Abrezekimab (anti-IL-13) is a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. It can be used in research of asthma. MW: 145.5 KD.

Product Details

CAS No. 2043952-59-4
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Abrezekimab (Anti-IL-13) | Abrezekimab (Anti-IL-13) supplier | purchase Abrezekimab (Anti-IL-13) | Abrezekimab (Anti-IL-13) cost | Abrezekimab (Anti-IL-13) manufacturer | order Abrezekimab (Anti-IL-13) | Abrezekimab (Anti-IL-13) distributor